Cargando…
Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients
Background: The clinical significance of KRAS exon 3/4 mutations in colorectal cancer (CRC) remains unclear. We aimed to assess the prognostic value of KRAS exons 3 and 4 mutations to determine the necessity for their testing. Methods: KRAS mutations in exon 2/3/4 were evaluated in 1816 stage I-IV p...
Autores principales: | Guo, Tianan, Wu, Yuchen, Huang, Dan, Jin, Yutong, Sheng, Weiqi, Cai, Sanjun, Zhou, Xiaoyan, Zhu, Xiaoli, Liu, Fangqi, Xu, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317521/ https://www.ncbi.nlm.nih.gov/pubmed/34335949 http://dx.doi.org/10.7150/jca.59193 |
Ejemplares similares
-
Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK-eIF2α Signaling
por: Zheng, Hongtu, et al.
Publicado: (2020) -
Rectovaginal fistula after low anterior resection in Chinese patients with colorectal cancer
por: Zheng, Hongtu, et al.
Publicado: (2017) -
Risk scoring system for recurrence after simultaneous resection of colorectal cancer liver metastasis
por: Wu, Yuchen, et al.
Publicado: (2021) -
SensiScreen(®)
KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations
por: Riva, Alice, et al.
Publicado: (2017) -
Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells
por: Wong, Hung Lai, et al.
Publicado: (2018)